China's Sinovac Biotech gets govt approval for more bird flu vaccine trials |
|
|
|
Published
:
Thu, 10 May 2007 11:04
|
BEIJING (XFN-ASIA) - Sinovac Biotech Ltd said China's State Food and Drug Administration has granted it approval to begin the Phase II clinical trial of Panflu, a human use vaccine against the H5N1 bird flu virus.The vaccine was jointly developed with China's Center for Disease Control, the company said in a statement, adding that two versions of the vaccine have been approved for clinical trials.'We are developing Panflu to vaccinate humans against H5N1 given the significant concern that it may evolve into a virus capable of human-to-human transmission,' said company president and CEO Yin Weidong.sean.mangieri@xfn.com
|
|
|
|
|
|
|
| Stock
Quotes * |
|
NASDAQ
|
|
1796.52 |
-49.20 (
-2.70 %)
|
| SYMBOL (
2009-07-03 ) |
| LAST |
CHANGE
|
|
CARNIVAL
(
11:35am )
|
|
1625.00 |
+15.00 (
0.93 %)
|
| SYMBOL (
2009-07-02 )
|
| LAST |
CHANGE
|
|
INTEL CP
(
4:00pm ) |
|
16.72 |
-0.32 (
-1.90 %)
|
| SYMBOL (
2009-07-02 )
|
| LAST |
CHANGE
|
|
|
Print this Story
FDA approves first bird flu vaccine 